Enrique Conterno

Type: Person
Name: Enrique Conterno
First reported Oct 29 2014 - Updated Oct 30 2014 - 3 reports

Boehringer Ingelheim, Lilly Restructure Diabetes Alliance

In a move that will strengthen their alliance by enhancing efficiencies and enabling greater focus on product launches, Boehringer Ingelheim and Eli Lilly and Company are changing the operational and financial structure of their diabetes alliance in certain ... [Published Drug Discovery and Development - Oct 29 2014]
First reported Oct 27 2014 - Updated Oct 27 2014 - 1 reports

Eli Lilly confident in its manufacturing for Insulin biosimilar market share

Eli Lilly’ manufacturing network will give it the edge in the glargine insulin market, the firm says having received tentative approval of its “ Lantus look-alike” from the USFDA.The Big Biopharma firm reported a downcast third quarter yesterday, with ... [Published In-Pharmatechnologist - Oct 27 2014]
First reported Oct 24 2014 - Updated Oct 24 2014 - 1 reports

Eli Lilly (LLY) Earnings Report: Q3 2014 Conference Call Transcript

, 09:00 AM ET. This is a transcript of that earnings call: Company Participants John Lechleiter; Eli Lilly; Chairman, CEO and President Phil Johnson; Eli Lilly; VP of Investor Relations Derica Rice; Eli Lilly; CFO, EVP of Global Enrique Conterno; ... [Published Lebanon Daily News - Oct 24 2014]
First reported Oct 24 2014 - Updated Oct 24 2014 - 1 reports

Eli Lilly and's (LLY) CEO John Lechleiter on Q3 2014 Results - Earnings Call Transcript

OperatorLadies and gentlemen, thank you for standing by and welcome to the Third Quarter Financial Review. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the conference over to our host, Chairman, President ... [Published Seeking Alpha - Oct 24 2014]
First reported Oct 03 2014 - Updated Oct 03 2014 - 2 reports

Humalog 200 units/ml KwikPen insulin gets marketing approval in EU for treatment of diabetes

Eli Lilly and Company today announced that the European Commission has granted marketing authorisation for Humalog® 200 units/ml KwikPen™ (insulin lispro 200 units/ml) for the treatment of diabetes in adults. Humalog 200 units/ml KwikPen is a prefilled ... [Published News-Medical.Net - Oct 03 2014]
Entities: Humalog, Insulin, Diabetes
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

Lilly set to release Trulicity pen for type 2 diabetes

INDIANAPOLIS – Eli Lilly and Co. has been cleared to market Trulicity, a medication for type 2 diabetes.Lilly said Thursday Trulicity (dulaglutide) has been approved by the Food and Drug Administration an adjunct to diet and exercise to improve glycemic ... [Published Chain Drug Review - Sep 23 2014]
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

Eli Lilly: A Full Suite Of Offerings For Diabetic Patients

Summary Recently, Eli Lilly and Boehringer Ingelheim received a positive opinion from the European Medicines Agency for its insulin glargine, Abasria, for the treatment of diabetes. It's the first copycat of Sanofi's blockbuster Lantus, which raked ... [Published Seeking Alpha - Sep 22 2014]
First reported Sep 20 2014 - Updated Sep 20 2014 - 1 reports

Eli Lilly's Trulicity receives US FDA approval to treat adults with type 2 diabetes

Eli Lilly and Company announced that the approval of Trulicity (dulaglutide) by the US Food and Drug Administration is the latest treatment option for adults with type 2 diabetes.Trulicity is indicated as an adjunct to diet and exercise to improve glycemic ... [Published PharmaBiz - Sep 20 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 1 reports

US FDA approves Jardiance tablets for adults with type 2 diabetes

Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company announced the US Food and Drug Administration (FDA) approved Jardiance (empagliflozin) tablets as an adjunct to diet and exercise to improve glycemic control, or blood glucose ... [Published PharmaBiz - Aug 05 2014]
First reported Jun 30 2014 - Updated Jun 30 2014 - 1 reports

CHMP recommends Lilly/Boehringer's new insulin glargine product for approval in EU to treat type 1 and type 2 diabete

The Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending approval for the investigational compound LY2963016, a new insulin glargine product, for the treatment of type 1 and type 2 diabetes. The new insulin glargine ... [Published PharmaBiz - Jun 30 2014]
First reported May 24 2014 - Updated May 24 2014 - 1 reports

EU grants marketing approval for Jardiance tabs to treat type 2 diabetes mellitus to improve glycemic control in adults

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company announced that the European Commission granted marketing authorization for Jardiance (empagliflozin) tablets, a sodium glucose co-transporter 2 (SGLT2) inhibitor, for the treatment of ... [Published PharmaBiz - May 24 2014]

More Content

All (16) | News (16) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Boehringer Ingelheim, Lilly Restructure Diabete... [Published Drug Discovery and Development - Oct 29 2014]
Lilly, Boehringer Ingelheim Restructure Diabete... [Published Genetic Engineering News - Oct 29 2014]
Boehringer Ingelheim and Lilly Revising Operati... [Published Boehringer Ingelheim - Oct 29 2014]
Boehringer Ingelheim and Lilly Revising Operati... [Published Asia Net - Oct 29 2014]
Eli Lilly confident in its manufacturing for In... [Published In-Pharmatechnologist - Oct 27 2014]
Eli Lilly (LLY) Earnings Report: Q3 2014 Confer... [Published Lebanon Daily News - Oct 24 2014]
Eli Lilly and's (LLY) CEO John Lechleiter on Q3... [Published Seeking Alpha - Oct 24 2014]
Humalog 200 units/ml KwikPen insulin gets marke... [Published News-Medical.Net - Oct 03 2014]
European Commission Grants Marketing Authorisat... [Published Michigan Live - Oct 03 2014]
Lilly set to release Trulicity pen for type 2 d... [Published Chain Drug Review - Sep 23 2014]
Eli Lilly: A Full Suite Of Offerings For Diabet... [Published Seeking Alpha - Sep 22 2014]
Eli Lilly's Trulicity receives US FDA approval ... [Published PharmaBiz - Sep 20 2014]
US FDA approves Jardiance tablets for adults wi... [Published PharmaBiz - Aug 05 2014]
CHMP recommends Lilly/Boehringer's new insulin ... [Published PharmaBiz - Jun 30 2014]
EU grants marketing approval for Jardiance tabs... [Published PharmaBiz - May 24 2014]
Lilly's phase III trial for once-weekly dulaglu... [Published PharmaBiz - Feb 27 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.